Activity Details
- Credit Amounts:
- Cost: Free
- Release: Jun 17, 2019
- Expires: Jun 17, 2020
-
Average User Rating:
( Ratings)
To complete this activity please click the link below
Click Here
Faculty

Associate Professor of Pharmacy Practice and Science
University of Maryland
Baltimore, Maryland

Professor of Psychiatry
University of Maryland Baltimore School of Medicine
Baltimore, Maryland
Target Audience
This activity is designed to meet the educational needs of psychiatric and neurologic pharmacists.Objectives
At the conclusion of this application-based activity, participants will be able to:1. Review the evidence base of long-acting injectable antipsychotics (LAI) compared to oral antipsychotics with regards to adherence, hospitalization, relapse, and mortality.
2. Identify the role of LAIs in the treatment continuum and discuss their use earlier in the schizophrenia disease course.
3. Compare LAIs with regard to pharmacokinetic profiles, loading dose strategies, and chronic dosing.
4. Incorporate LAIs into treatment regimens using case-based examples